Arcturus Therapeutics Holdings (ARCT) Metrics: History & Chart

Arcturus Therapeutics Holdings Inc.(ARCT)

Biotechnology · San Diego, CA

$14.70+0.04 (+0.27%)

Delayed quote: Oct 6, 2026, 9:30 AM EDT

About Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc. is a biotechnology company focused on RNA-based medicines, developing a pipeline of vaccines for infectious diseases alongside treatments for rare liver and respiratory conditions across the United States. Its notable development programs encompass LUNAR-OTC, designed for ornithine transcarbamylase (OTC) deficiency, and LUNAR-CF, targeting cystic fibrosis lung disease caused by specific CFTR gene mutations. The company also advances vaccine initiatives such as LUNAR-COV19 and LUNAR-FLU. Arcturus has cultivated a range of strategic collaborations, including partnerships with Vinbiocare Biotechnology Joint Stock Company for manufacturing COVID-19 vaccines; Janssen Pharmaceuticals, Inc., to create nucleic acid-based therapies for hepatitis B virus; Ultragenyx Pharmaceutical, Inc., for developing mRNA therapeutics aimed at rare disease targets; CureVac AG, to progress mRNA therapeutic and vaccine candidates across various indications; the Singapore Economic Development Board and Duke-NUS Medical School, specifically for the LUNAR-COV19 vaccine; and Millennium Pharmaceuticals, Inc., focused on discovering siRNA medicines for non-alcoholic steatohepatitis (NASH). Founded in 2013, Arcturus Therapeutics maintains its corporate headquarters in San Diego, California.

San Diego, CA

109 employees

arcturusrx.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Joseph E. Payne

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	+1.38%
30D Total Return	-7.33%
YTD Total Return	+139.15%
1Y Total Return	-35.02%
3Y Total Return	-42.31%
5Y Total Return	-64.54%
10Y Total Return	-22.68%
15Y Total Return	N/A
20Y Total Return	N/A

2026	+139.15%
2025	-63.88%
2024	-46.18%
2023	+85.91%
2022	-54.17%
2021	-14.68%
2020

CAGR TTM	-34.88%
CAGR 3Y	-16.75%
CAGR 5Y	-18.73%
CAGR 10Y	-2.54%
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	10.07
PE Ratio Avg TTM	8.20
PE Ratio Avg 3Y	8.20
Current VS TTM Avg	+22.85%
Current VS 3Y Avg	+22.85%
Current VS 5Y Avg	+22.85%

All Metrics

ARCT Valuation Metrics

ARCT Stock Price Metrics

ARCT Dividend Metrics

ARCT Growth Rate Metrics

ARCT Discounted Cash Flow Metrics

ARCT Returns By Period

ARCT Yearly Returns

ARCT Average Annual Returns By Period (CAGR)

ARCT Revenue Metrics

ARCT PE Ratio Metrics

ARCT PS Ratio Metrics

ARCT PB Ratio Metrics

ARCT Price to Free Cash Flow Ratio Metrics

ARCT Debt to Equity Ratio Metrics

ARCT PEG Ratio Metrics

ARCT FCF Yield

ARCT Earnings Yield

ARCT EBITDA Yield

ARCT OCF Yield

ARCT EV/EBIT Ratio Metrics

ARCT EV/EBITDA Ratio Metrics

ARCT EV/Assets Ratio Metrics

ARCT EV/Sales Ratio Metrics

ARCT Current Ratio Metrics

ARCT Quick Ratio Metrics

ARCT ROIC Metrics

ARCT Return on Assets Metrics

ARCT Return on Equity Metrics

ARCT Net Profit Margin Metrics

ARCT Gross Profit Margin Metrics

ARCT Tax Rate Metrics

PS Ratio	17.51
PS Ratio Avg TTM	3.15
PS Ratio Avg 3Y	3.38
Current VS TTM Avg	+455.70%
Current VS 3Y Avg	+417.75%
Current VS 5Y Avg	+259.97%

PB Ratio	2.43
PB Ratio Avg TTM	0.98
PB Ratio Avg 3Y	1.88
Current VS TTM Avg	+147.13%
Current VS 3Y Avg	+29.15%
Current VS 5Y Avg	+6.97%

PFCF Ratio	54.47
PFCF Ratio Avg TTM	25.86
PFCF Ratio Avg 3Y	17.69
Current VS TTM Avg	+110.61%
Current VS 3Y Avg	+207.91%
Current VS 5Y Avg	+207.91%

Debt/Equity Ratio	0.13
Debt/Equity Ratio Avg TTM	0.12
Debt/Equity Ratio Avg 3Y	0.12
Current VS TTM Avg	+9.76%
Current VS 3Y Avg	+12.89%
Current VS 5Y Avg	-22.61%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	1.84%
FCF Yield Avg TTM	13.37%
FCF Yield Avg 3Y	10.70%
Current VS TTM Avg	-86.24%
Current VS 3Y Avg	-82.81%
Current VS 5Y Avg	-82.81%

Earnings Yield	9.93%
Earnings Yield Avg TTM	12.83%
Earnings Yield Avg 3Y	12.83%
Current VS TTM Avg	-22.59%
Current VS 3Y Avg	-22.59%
Current VS 5Y Avg	-22.59%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	11.47
Ev/Ebit Ratio Avg TTM	8.40
Ev/Ebit Ratio Avg 3Y	8.40
Current VS TTM Avg	+36.61%
Current VS 3Y Avg	+36.61%
Current VS 5Y Avg	+36.61%

Ev/Ebitda Ratio	10.99
Ev/Ebitda Ratio Avg TTM	8.11
Ev/Ebitda Ratio Avg 3Y	8.11
Current VS TTM Avg	+35.54%
Current VS 3Y Avg	+35.54%
Current VS 5Y Avg	+35.54%

Ev/Assets Ratio	1.11
Ev/Assets Ratio Avg TTM	0.14
Ev/Assets Ratio Avg 3Y	0.71
Current VS TTM Avg	+694.51%
Current VS 3Y Avg	+56.88%
Current VS 5Y Avg	+35.01%

Ev/Sales Ratio	10.43
Ev/Sales Ratio Avg TTM	0.54
Ev/Sales Ratio Avg 3Y	1.71
Current VS TTM Avg	+1819.01%
Current VS 3Y Avg	+510.57%
Current VS 5Y Avg	+237.34%

Current Ratio	5.88
Current Ratio Avg TTM	6.52
Current Ratio Avg 3Y	5.24
Current VS TTM Avg	-9.80%
Current VS 3Y Avg	+12.11%
Current VS 5Y Avg	+24.64%

Quick Ratio	5.88
Quick Ratio Avg TTM	6.52
Quick Ratio Avg 3Y	5.24
Current VS TTM Avg	-9.80%
Current VS 3Y Avg	+12.11%
Current VS 5Y Avg	+24.64%

ROIC	(54.07%)
ROIC Avg 3Y	(31.66%)
ROIC Avg 5Y	(37.71%)
Current VS 3Y Avg	-70.78%
Current VS 5Y Avg	-43.35%
Current VS 10Y Avg	-31.03%

ROA	(41.58%)
ROA Avg TTM	(8.01%)
ROA Avg 3Y	(6.48%)
Current VS TTM Avg	-419.15%
Current VS 3Y Avg	-542.14%
Current VS 5Y Avg	-419.75%

ROE	(54.29%)
ROE Avg TTM	(36.38%)
ROE Avg 3Y	(29.34%)
Current VS TTM Avg	-49.24%
Current VS 3Y Avg	-85.02%
Current VS 5Y Avg	-31.72%

Net Profit Margin	(391.90%)
Net Profit Margin Avg TTM	(1256.77%)
Net Profit Margin Avg 3Y	(231.29%)
Current VS TTM Avg	+68.82%
Current VS 3Y Avg	-69.44%
Current VS 5Y Avg	-52.51%

Gross Profit Margin	95.50%
Gross Pft Margin Avg TTM	74.53%
Gross Pft Margin Avg 3Y	100.00%
Current VS TTM Avg	+28.14%
Current VS 3Y Avg	-4.50%
Current VS 5Y Avg	+57.18%

Tax Rate	0.20%
Tax Rate Avg 3Y	0.65%
Tax Rate Avg 5Y	0.65%
Current VS 3Y Avg	-68.70%
Current VS 5Y Avg	-68.70%
Current VS 10Y Avg	-68.70%